To Check Safety and efficacy of Baypure Brightening Vitamin C Serum for Skin Brightness

A Single-Arm Clinical Study to evaluate the Safety and effectiveness of Baypure Brightening Vitamin C Serum for Skin Brightness - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2026/04/107723

Enrollment

Registered

2026-04-07

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product: Brightening Vitamin C Serum: Apply 5-6 Drops on face and neck twice a day, Route of Administration: Topical, Duration: 28 Days Control Intervention1: Not Applicable: Not A

Eligibility

Inclusion criteria

Inclusion criteria: 1. Males and females aged 18 45 years. 2. Subjects with dull and/or mild pigmented skin. 3. Willingnessto provide written informed consent. 4. Female participants of childbearing potential: negative urine pregnancy test at screening. 5. Willing to avoid excessive sun exposure during study duration. 6. Free from systemic or dermatological disorders that may interfere with results.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women, or those planning pregnancy during the study. 2. History of skin cancers within the past 5 years. 3. Presence of active skin disease, open lesions, or infections in the treatment area. 4. Known allergy to Vitamin C or excipients in the test product. 5. Use ofsystemic corticosteroids, immunosuppressive, or biologic therapies within 90 days. 6. Participation in another interventional study within the past 90 days.

Design outcomes

Primary

Measure	Time frame
1. Change in Skin dark spots 2. Change in Skin gloss 3. Change in Skin Pigmentation 4. Change in Dermatological Evaluation 5. DSLR ImagingTimepoint: At Day 0, Day 7, Day 14, Day 21 & Day 28	—

Secondary

Measure	Time frame
1. Change in Hydration 2. Change in TEWLTimepoint: At Day 0, 30 min, Day 7, Day 14, Day 21 & Day 28	—

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org08937015757

Outcome results